InvestorsHub Logo
Followers 29
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 39817

Friday, 06/04/2021 10:10:29 PM

Friday, June 04, 2021 10:10:29 PM

Post# of 44695
AMAZING NEUROPEPTIDE

Vasoactive intestinal peptide (VIP) has recently been shown to bind to human lymphocytes and modulate immune functions. The ability of VIP in restoring natural killer (NK) cell activity depressed by hepatitis B surface antigen (HBsAg) has been investigated in the present research.

https://pubmed.ncbi.nlm.nih.gov/1418317/

The global hepatitis therapeutics market size was estimated at USD 21.9 billion in 2019 and is expected to reach USD 22.5 billion in 2020.

https://www.grandviewresearch.com/industry-analysis/hepatitis-therapeutics-market